EIT Health, a network of best-in-class innovators backed by the EU, has announced the second year of its innovation programme, Wild Card.
Individuals will be...
The team behind a unique Breath Biopsy® platform that has the potential to save hundreds of thousands of lives and $1.5 billion in healthcare costs globally, ha...
By @SimonCocking
Describe the company – the elevator pitch...
Biosensia Ltd, an Irish biotech company, has developed RapiPlex; a multiplexing, low-cost, Point-of-Care (PoC) diagnostic platform. The system is a fluorescent immunoassay based opti...
OncoMark, a University College Dublin (UCD) spin-out company, has been selected for €2.7 million in funding over 2-years, through the latest round of Horizon 20...
